Pink SheetA political official is negotiating the postmarketing commitment with Novavax that delayed its COVID-19 vaccine approval, continuing the pattern of highly unusual political involvement with the appl
Pink SheetThe US Food and Drug Administration has requested an unusual last-minute postmarketing commitment from Novavax to move the company’s COVID-19 vaccine to traditional approval, the company reported th
ScripResults from a Phase III study in China of Akeso and Summit Therapeutics’ ivonescimab in non-small cell lung cancer (NSCLC) are an encouraging sign for the PD-1/VEGF-targeting bispecific antibody’s pi
ScripScancell has become the second biopharma company – after BioNTech – to join a UK government program designed to accelerate research into personalized cancer vaccines. The Oxford-based firm has announc